162 related articles for article (PubMed ID: 27283127)
21. Effects of zinc and ferritin levels on parent and teacher reported symptom scores in attention deficit hyperactivity disorder.
Oner O; Oner P; Bozkurt OH; Odabas E; Keser N; Karadag H; Kizilgün M
Child Psychiatry Hum Dev; 2010 Aug; 41(4):441-7. PubMed ID: 20238159
[TBL] [Abstract][Full Text] [Related]
22. Iron deficiency in children with attention deficit hyperactivity disorder.
Lahat E; Heyman E; Livne A; Goldman M; Berkovitch M; Zachor D
Isr Med Assoc J; 2011 Sep; 13(9):530-3. PubMed ID: 21991711
[TBL] [Abstract][Full Text] [Related]
23. Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD.
Bralten J; Franke B; Waldman I; Rommelse N; Hartman C; Asherson P; Banaschewski T; Ebstein RP; Gill M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant JA; Oosterlaan J; Sonuga-Barke E; Steinhausen HC; Faraone SV; Buitelaar JK; Arias-Vásquez A
J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1204-1212.e1. PubMed ID: 24157394
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D deficiency in school-age Iranian children with attention-deficit/hyperactivity disorder (ADHD) symptoms: A critical comparison with healthy controls.
Fasihpour B; Moayeri H; Shariat M; Keihanidoust Z; Effatpanah M; Khedmat L
Child Neuropsychol; 2020 May; 26(4):460-474. PubMed ID: 31514566
[TBL] [Abstract][Full Text] [Related]
25. Autism spectrum disorder symptoms in children with ADHD: A community-based study.
Green JL; Rinehart N; Anderson V; Nicholson JM; Jongeling B; Sciberras E
Res Dev Disabil; 2015 Dec; 47():175-84. PubMed ID: 26433184
[TBL] [Abstract][Full Text] [Related]
26. Low blood levels of lead and mercury and symptoms of attention deficit hyperactivity in children: a report of the children's health and environment research (CHEER).
Ha M; Kwon HJ; Lim MH; Jee YK; Hong YC; Leem JH; Sakong J; Bae JM; Hong SJ; Roh YM; Jo SJ
Neurotoxicology; 2009 Jan; 30(1):31-6. PubMed ID: 19100765
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of iron supplementation in a young child with attention-deficit/hyperactivity disorder.
Konofal E; Cortese S; Lecendreux M; Arnulf I; Mouren MC
Pediatrics; 2005 Nov; 116(5):e732-4. PubMed ID: 16263988
[TBL] [Abstract][Full Text] [Related]
28. Resting metabolic rate, pulmonary functions, and body composition parameters in children with attention deficit hyperactivity disorder.
Alpaslan AH; Ucok K; Coşkun KŞ; Genc A; Karabacak H; Guzel HI
Eat Weight Disord; 2017 Mar; 22(1):91-96. PubMed ID: 26573986
[TBL] [Abstract][Full Text] [Related]
29. The assessment of serum lipid profiles of children with attention deficit hyperactivity disorder.
Ugur C; Uneri OS; Goker Z; Sekmen E; Aydemir H; Solmaz E
Psychiatry Res; 2018 Jun; 264():231-235. PubMed ID: 29655116
[TBL] [Abstract][Full Text] [Related]
30. Association between altered lipid profiles and attention deficit hyperactivity disorder in boys.
Avcil S
Nord J Psychiatry; 2018 Jul; 72(5):361-366. PubMed ID: 29688116
[TBL] [Abstract][Full Text] [Related]
31. Decreased platelet vesicular monoamine transporter density in children and adolescents with attention deficit/hyperactivity disorder.
Toren P; Rehavi M; Luski A; Roz N; Laor N; Lask M; Weizman A
Eur Neuropsychopharmacol; 2005 Mar; 15(2):159-62. PubMed ID: 15695060
[TBL] [Abstract][Full Text] [Related]
32. Validation of the French Version of Conners' Parent Rating Scale-Revised, Short Form in ADHD-Diagnosed Children and Comparison With Control Children.
Fumeaux P; Mercier C; Roche S; Iwaz J; Stéphan P; Revol O
J Atten Disord; 2021 Jan; 25(1):124-133. PubMed ID: 29562852
[No Abstract] [Full Text] [Related]
33. Combined type versus ADHD predominantly hyperactive-impulsive type: is there a difference in functional impairment?
Riley C; DuPaul GJ; Pipan M; Kern L; Van Brakle J; Blum NJ
J Dev Behav Pediatr; 2008 Aug; 29(4):270-5. PubMed ID: 18454040
[TBL] [Abstract][Full Text] [Related]
34. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study.
Colter AL; Cutler C; Meckling KA
Nutr J; 2008 Feb; 7():8. PubMed ID: 18275609
[TBL] [Abstract][Full Text] [Related]
35. Reduced platelet monoamine oxidase type B activity and lymphocyte muscarinic receptor binding in unmedicated children with attention deficit hyperactivity disorder.
Coccini T; Crevani A; Rossi G; Assandri F; Balottin U; Nardo RD; Manzo L
Biomarkers; 2009 Nov; 14(7):513-22. PubMed ID: 19863190
[TBL] [Abstract][Full Text] [Related]
36. Increased levels of plasma glial-derived neurotrophic factor in children with attention deficit hyperactivity disorder.
Shim SH; Hwangbo Y; Yoon HJ; Kwon YJ; Lee HY; Hwang JA; Kim YK
Nord J Psychiatry; 2015; 69(7):546-51. PubMed ID: 25753832
[TBL] [Abstract][Full Text] [Related]
37. [Zinc in the therapy of the attention-deficit/hyperactivity disorder in children. A preliminar randomized controlled trial].
Zamora J; Velásquez A; Troncoso L; Barra P; Guajardo K; Castillo-Duran C
Arch Latinoam Nutr; 2011 Sep; 61(3):242-6. PubMed ID: 22696891
[TBL] [Abstract][Full Text] [Related]
38. Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children.
Konofal E; Cortese S; Marchand M; Mouren MC; Arnulf I; Lecendreux M
Sleep Med; 2007 Nov; 8(7-8):711-5. PubMed ID: 17644481
[TBL] [Abstract][Full Text] [Related]
39. Ubiquinone Levels as a Marker of Antioxidant System in Children with Attention Deficit Hyperactivity Disorder.
Karagöz YS; Doğan Ö; Elgün S; Öztop DB; Kılıç BG
J Mol Neurosci; 2021 Oct; 71(10):2173-2178. PubMed ID: 33245486
[TBL] [Abstract][Full Text] [Related]
40. Thiols and ceruloplasmin levels in serum of children with attention deficit hyperactivity disorder: A cross-sectional study.
Öğütlü H; Mertoğlu C; Gök G; Neşelioğlu S
Psychiatry Res; 2020 Dec; 294():113546. PubMed ID: 33160216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
